Alexander Ratushny, PhD

Senior Director
Bristol Myers Squibb

Poster(s):

• (M-014) Multiple myeloma QSP model enables evaluation of iberdomide dosing schedules post-ASCT in NDMM patients for the EXCALIBER Maintenance study
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT